Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marianne D Sadar Insider Profile
4 Followers
Marianne D Sadar, Chief Scientific Officer, Ten Percent Owner at ESSA Pharma, holds 2.89M shares in ESSA Pharma (Ticker: EPIX). Most recently, Marianne D Sadar ― shares of ESSA Pharma on ― for an estimated value of ―.
Marianne D Sadar has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marianne D Sadar's holdings
Insider Roles
Chief Scientific Officer, Ten Percent Owner
Roles that Marianne D Sadar holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Marianne D Sadar
Marianne D Sadar's Trading History
List of latest transactions for each holding click on a transaction to see Marianne D Sadar's performance on stock
You May Also Like
Marianne D Sadar insider profile FAQ
What is the percentage of profitable transactions made by Marianne D Sadar?
The percentage of profitable transactions made by Marianne D Sadar is ―.
What is the average return per transaction made by Marianne D Sadar?
The average return per transaction made by Marianne D Sadar is ―.
What stocks does Marianne D Sadar hold?
Marianne D Sadar holds: EPIX stocks.
What was Marianne D Sadar’s latest transaction?
Marianne D Sadar latest transaction was an Uninformative Buy of ―.
What was Marianne D Sadar's most profitable transaction?
Marianne D Sadar’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Marianne D Sadar's role in ESSA Pharma?
Marianne D Sadar's role in ESSA Pharma is Chief Scientific Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.